Aligos Therapeutics Stock (NASDAQ: ALGS) stock price, news, charts, stock research, profile.
Open | $0.52 |
Close | - |
Volume / Avg. | 184.23K / 399.49K |
Day Range | 0.50 - 0.54 |
52 Wk Range | 0.35 - 1.20 |
Market Cap | $40.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.56% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.
Other companies in Aligos Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), CARISMA Therapeutics (NASDAQ:CARM) and Curis (NASDAQ:CRIS).
There is no analysis for Aligos Therapeutics.
Aligos Therapeutics has a consensus price target of $6.00.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $0.529 last updated Today at July 25, 2024 at 9:26 AM EDT.
There are no upcoming dividends for Aligos Therapeutics.
Aligos Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.